108 related articles for article (PubMed ID: 31646549)
1. MNX1-AS1 accelerates the epithelial-mesenchymal transition in osteosarcoma cells by activating MNX1 as a functional oncogene.
Wu F; Zhong Y; Lang XB; Tu YL; Sun SF
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8194-8202. PubMed ID: 31646549
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA MNX1-AS1 functions as a competing endogenous RNA to regulate epithelial-mesenchymal transition by sponging MiR-744-5p in colorectal cancer.
Huang S; Sun Y
Biosci Biotechnol Biochem; 2021 Feb; 85(3):568-578. PubMed ID: 33590038
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA MNX1-AS1 promoted osteosarcoma proliferation and invasion via inhibiting KISS1.
Zhang YX; Cui HX; Liu L; Yi GK
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6045-6052. PubMed ID: 31364121
[TBL] [Abstract][Full Text] [Related]
4. Upregulated expression of MNX1-AS1 long noncoding RNA predicts poor prognosis in gastric cancer.
Zhang W; Huang L; Lu X; Wang K; Ning X; Liu Z
Bosn J Basic Med Sci; 2019 May; 19(2):164-171. PubMed ID: 30821221
[TBL] [Abstract][Full Text] [Related]
5. MNX1-AS1 is a functional oncogene that induces EMT and activates the AKT/mTOR pathway and MNX1 in breast cancer.
Cheng Y; Pan Y; Pan Y; Wang O
Cancer Manag Res; 2019; 11():803-812. PubMed ID: 30697072
[TBL] [Abstract][Full Text] [Related]
6. LncRNA FLVCR1-AS1 accelerates osteosarcoma cells to proliferate, migrate and invade via activating wnt/β-catenin pathway.
Jiang S; Kong P; Liu X; Yuan C; Peng K; Liang Y
J BUON; 2020; 25(4):2078-2085. PubMed ID: 33099956
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA MNX1-AS1 overexpression promotes the invasion and metastasis of gastric cancer through repressing CDKN1A.
Ma JX; Yang YL; He XY; Pan XM; Wang Z; Qian YW
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4756-4762. PubMed ID: 31210302
[TBL] [Abstract][Full Text] [Related]
8. Long Noncoding RNA MNX1 antisense RNA 1 Exerts Oncogenic Functions in Bladder Cancer by Regulating miR-218-5p/RAB1A Axis.
Wang J; Xing H; Nikzad AA; Liu B; Zhang Y; Li S; Zhang E; Jia Z
J Pharmacol Exp Ther; 2020 Mar; 372(3):237-247. PubMed ID: 31843814
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of lncRNA MNX1-AS1 suppresses cell proliferation, migration, and invasion in prostate cancer.
Li Z; Wang F; Zhang S
FEBS Open Bio; 2019 May; 9(5):851-858. PubMed ID: 30980513
[TBL] [Abstract][Full Text] [Related]
10. E2F1-mediated MNX1-AS1-miR-218-5p-SEC61A1 feedback loop contributes to the progression of colon adenocarcinoma.
Ye Y; Gu B; Wang Y; Shen S; Huang W
J Cell Biochem; 2019 Apr; 120(4):6145-6153. PubMed ID: 30362161
[TBL] [Abstract][Full Text] [Related]
11. Prognostic potential of MNX1-AS1 in chemotherapy of colorectal carcinoma.
Zhong G; Zhou M; Wang Z; Zhu W
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):243-247. PubMed ID: 38279423
[TBL] [Abstract][Full Text] [Related]
12. LncRNA MNX1-AS1 promotes the progression of cervical cancer through activating MAPK pathway.
Liu X; Yang Q; Yan J; Zhang X; Zheng M
J Cell Biochem; 2019 Mar; 120(3):4268-4277. PubMed ID: 30302806
[TBL] [Abstract][Full Text] [Related]
13. Long Noncoding RNA MNX1-AS1 Knockdown Inhibits Cell Proliferation and Migration in Ovarian Cancer.
Lv Y; Li H; Li F; Liu P; Zhao X
Cancer Biother Radiopharm; 2017 Apr; 32(3):91-99. PubMed ID: 28414551
[TBL] [Abstract][Full Text] [Related]
14. LncRNA FBXL19-AS1 promotes proliferation and metastasis via regulating epithelial-mesenchymal transition in non-small cell lung cancer.
Yu DJ; Li YH; Zhong M
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4800-4806. PubMed ID: 31210311
[TBL] [Abstract][Full Text] [Related]
15. Sex-determining region Y-box protein 3 induces epithelial-mesenchymal transition in osteosarcoma cells via transcriptional activation of Snail1.
Qiu M; Chen D; Shen C; Shen J; Zhao H; He Y
J Exp Clin Cancer Res; 2017 Mar; 36(1):46. PubMed ID: 28335789
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA MNX1-AS1 promotes migration and invasion of esophageal squamous cell carcinoma by upregulating IGF2.
Zheng DN; Zhang CJ; Sun GP
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6179-6185. PubMed ID: 31364117
[TBL] [Abstract][Full Text] [Related]
17. LncRNA MNX1-AS1 promotes progression of esophageal squamous cell carcinoma by regulating miR-34a/SIRT1 axis.
Chu J; Li H; Xing Y; Jia J; Sheng J; Yang L; Sun K; Qu Y; Zhang Y; Yin H; Wan J; He F
Biomed Pharmacother; 2019 Aug; 116():109029. PubMed ID: 31170665
[TBL] [Abstract][Full Text] [Related]
18. Irisin reverses the IL-6 induced epithelial-mesenchymal transition in osteosarcoma cell migration and invasion through the STAT3/Snail signaling pathway.
Kong G; Jiang Y; Sun X; Cao Z; Zhang G; Zhao Z; Zhao Y; Yu Q; Cheng G
Oncol Rep; 2017 Nov; 38(5):2647-2656. PubMed ID: 29048621
[TBL] [Abstract][Full Text] [Related]
19. Visfatin promotes osteosarcoma cell migration and invasion via induction of epithelial-mesenchymal transition.
Cheng G; Liu C; Sun X; Zhang L; Liu L; Ouyang J; Li B
Oncol Rep; 2015 Aug; 34(2):987-94. PubMed ID: 26062797
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of lncRNA MNX1-AS1 is associated with poor clinical outcome in epithelial ovarian cancer.
Li AH; Zhang HH
Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5618-5623. PubMed ID: 29271994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
